Skip to main content
OpenTrials

Clinical trial condition

Alphavirus Infections

Explore clinical trials studying Alphavirus Infections. Study availability and eligibility vary by location and protocol.

77 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Alphavirus Infections trial results

Completed

Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine

NCT02861586

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +11 more
Locations
  • Hansa Sanatorium GmbH Graz, Austria
  • Medical University Vienna, Department of Clinical Pharmacology Vienna, Austria
  • Berliner Center for Travel- and Tropical Medicine Berlin, Germany
  • Medicinal University Rostock, Department for Tropical Medicin and infectious diseases Rostock, Germany
View Trial Details
Completed

The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico

NCT02831699

Conditions
Alphavirus Infections, Arbovirus Infections, Autoimmune Diseases, +28 more
Locations
  • Hospital General de Tapachula Tapachula, Chiapas, Mexico
  • Hospital Regional de Alta Especialidad Ciudad Salud Chiapas, Mexico
  • Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE) Clínica Hospital Dr. Roberto Nettel Flores Chiapas, Mexico
  • Instituto Mexicano del Seguro Social (IMSS) Delegación Estatal / Hospital General de Zona con Medicina Familiar No. 1 Chiapas, Mexico
View Trial Details
Completed

Phase I Trial of Measles Vectored Chikungungya Vaccine

NCT03028441

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +11 more
Locations
  • Emory Children's Center - Pediatric Infectious Diseases Atlanta, Georgia, United States
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • Baylor College of Medicine - Molecular Virology and Microbiology Houston, Texas, United States
View Trial Details

Related conditions